| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.64e-07 | 20 | 50 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.93e-06 | 36 | 50 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.36e-06 | 50 | 50 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 9.30e-06 | 53 | 50 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.05e-04 | 188 | 50 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.16e-04 | 192 | 50 | 5 | GO:0016853 | |
| GeneOntologyMolecularFunction | frizzled binding | 1.58e-04 | 42 | 50 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.19e-04 | 9 | 50 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.19e-04 | 9 | 50 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 3.99e-04 | 12 | 50 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 6.51e-04 | 279 | 50 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.60e-03 | 507 | 50 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.60e-03 | 507 | 50 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.07e-03 | 27 | 50 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 3.11e-03 | 398 | 50 | 5 | GO:0061659 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.14e-09 | 20 | 51 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.14e-09 | 9 | 51 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.89e-09 | 10 | 51 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.33e-08 | 13 | 51 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.26e-08 | 14 | 51 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.30e-06 | 38 | 51 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.57e-06 | 54 | 51 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.85e-05 | 71 | 51 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | mRNA transport | 2.90e-05 | 145 | 51 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 7.11e-05 | 175 | 51 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 7.11e-05 | 175 | 51 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.71e-05 | 178 | 51 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 9.25e-05 | 185 | 51 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.18e-04 | 195 | 51 | 5 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.36e-04 | 201 | 51 | 5 | GO:0051170 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.63e-04 | 111 | 51 | 4 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.87e-04 | 115 | 51 | 4 | GO:0019319 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.95e-04 | 217 | 51 | 5 | GO:0006403 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 1.97e-04 | 344 | 51 | 6 | GO:0060070 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 2.13e-04 | 9 | 51 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.28e-04 | 121 | 51 | 4 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.17e-04 | 132 | 51 | 4 | GO:0043255 | |
| GeneOntologyBiologicalProcess | nuclear transport | 3.27e-04 | 378 | 51 | 6 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 3.27e-04 | 378 | 51 | 6 | GO:0006913 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.36e-04 | 134 | 51 | 4 | GO:0010906 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 3.54e-04 | 247 | 51 | 5 | GO:0016051 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.68e-04 | 249 | 51 | 5 | GO:0015931 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 4.71e-04 | 405 | 51 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 4.73e-04 | 569 | 51 | 7 | GO:0034329 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 7.04e-04 | 16 | 51 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | synapse assembly | 9.62e-04 | 308 | 51 | 5 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 9.98e-04 | 19 | 51 | 2 | GO:0090175 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.18e-09 | 8 | 51 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.53e-09 | 10 | 51 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.09e-08 | 14 | 51 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.37e-08 | 18 | 51 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.48e-07 | 20 | 51 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | 1.65e-07 | 101 | 51 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.82e-07 | 21 | 51 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 2.66e-06 | 90 | 51 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.74e-04 | 656 | 51 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.78e-04 | 658 | 51 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | nuclear envelope | 3.97e-04 | 560 | 51 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 4.47e-04 | 13 | 51 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | Wnt signalosome | 6.85e-04 | 16 | 51 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.31e-03 | 22 | 51 | 2 | GO:0031258 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.58e-03 | 349 | 51 | 5 | GO:0031965 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.78e-03 | 934 | 51 | 8 | GO:0048471 | |
| GeneOntologyCellularComponent | catenin complex | 2.76e-03 | 32 | 51 | 2 | GO:0016342 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 4.20e-03 | 133 | 51 | 3 | GO:0005881 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 9.19e-08 | 16 | 39 | 4 | MP:0003701 | |
| MousePheno | aneuploidy | 6.88e-07 | 61 | 39 | 5 | MP:0004024 | |
| MousePheno | abnormal morula morphology | 7.40e-07 | 26 | 39 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 1.35e-06 | 30 | 39 | 4 | MP:0010308 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.37e-06 | 70 | 39 | 5 | MP:0003331 | |
| MousePheno | failure of blastocyst formation | 1.54e-06 | 31 | 39 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 2.26e-06 | 34 | 39 | 4 | MP:0010307 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.35e-06 | 141 | 39 | 6 | MP:0004499 | |
| MousePheno | abnormal chromosome number | 3.83e-06 | 86 | 39 | 5 | MP:0004023 | |
| MousePheno | abnormal blastocyst formation | 3.97e-06 | 39 | 39 | 4 | MP:0012128 | |
| MousePheno | increased incidence of induced tumors | 7.66e-06 | 173 | 39 | 6 | MP:0002021 | |
| MousePheno | increased sarcoma incidence | 8.86e-06 | 102 | 39 | 5 | MP:0002032 | |
| MousePheno | increased tumor incidence | 1.16e-05 | 530 | 39 | 9 | MP:0002020 | |
| MousePheno | increased liver tumor incidence | 1.34e-05 | 111 | 39 | 5 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.34e-05 | 111 | 39 | 5 | MP:0010297 | |
| MousePheno | abnormal rod electrophysiology | 1.88e-05 | 119 | 39 | 5 | MP:0004021 | |
| MousePheno | abnormal chromosome morphology | 2.47e-05 | 126 | 39 | 5 | MP:0003702 | |
| MousePheno | abnormal mitosis | 2.67e-05 | 128 | 39 | 5 | MP:0004046 | |
| MousePheno | neoplasm | 2.76e-05 | 747 | 39 | 10 | MP:0002006 | |
| MousePheno | increased malignant tumor incidence | 4.55e-05 | 237 | 39 | 6 | MP:0002018 | |
| MousePheno | abnormal tumor incidence | 4.84e-05 | 635 | 39 | 9 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 5.81e-05 | 650 | 39 | 9 | MP:0002166 | |
| MousePheno | increased lung carcinoma incidence | 6.36e-05 | 78 | 39 | 4 | MP:0008714 | |
| MousePheno | increased classified tumor incidence | 7.66e-05 | 381 | 39 | 7 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 8.04e-05 | 384 | 39 | 7 | MP:0020188 | |
| MousePheno | abnormal incidence of induced tumors | 9.19e-05 | 269 | 39 | 6 | MP:0013151 | |
| MousePheno | increased organ/body region tumor incidence | 9.60e-05 | 395 | 39 | 7 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 1.05e-04 | 401 | 39 | 7 | MP:0013152 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.29e-04 | 286 | 39 | 6 | MP:0008873 | |
| MousePheno | abnormal cell nucleus morphology | 1.50e-04 | 184 | 39 | 5 | MP:0003111 | |
| MousePheno | increased susceptibility to infection induced morbidity/mortality | 1.54e-04 | 185 | 39 | 5 | MP:0009787 | |
| MousePheno | enlarged epididymis | 1.61e-04 | 99 | 39 | 4 | MP:0004931 | |
| MousePheno | increased susceptibility to bacterial infection induced morbidity/mortality | 1.81e-04 | 102 | 39 | 4 | MP:0009788 | |
| MousePheno | increased carcinoma incidence | 2.06e-04 | 197 | 39 | 5 | MP:0002038 | |
| MousePheno | increased lung tumor incidence | 2.17e-04 | 107 | 39 | 4 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 2.17e-04 | 107 | 39 | 4 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 2.17e-04 | 107 | 39 | 4 | MP:0010298 | |
| MousePheno | abnormal blastocyst hatching | 2.68e-04 | 113 | 39 | 4 | MP:0003693 | |
| MousePheno | abnormal eye electrophysiology | 4.05e-04 | 228 | 39 | 5 | MP:0005551 | |
| MousePheno | absent forebrain | 6.76e-04 | 14 | 39 | 2 | MP:0012136 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 9.95e-04 | 160 | 39 | 4 | MP:0005659 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 1.01e-03 | 279 | 39 | 5 | MP:0009785 | |
| MousePheno | abnormal epididymis size | 1.14e-03 | 166 | 39 | 4 | MP:0004926 | |
| MousePheno | abnormal preimplantation embryo development | 1.27e-03 | 171 | 39 | 4 | MP:0009781 | |
| MousePheno | abnormal eye physiology | 1.27e-03 | 606 | 39 | 7 | MP:0005253 | |
| MousePheno | decreased susceptibility to weight gain | 1.73e-03 | 186 | 39 | 4 | MP:0010182 | |
| MousePheno | abnormal response to novel object | 1.81e-03 | 87 | 39 | 3 | MP:0003461 | |
| Domain | Grip | 5.66e-11 | 11 | 51 | 5 | SM00755 | |
| Domain | GRIP | 5.66e-11 | 11 | 51 | 5 | PF01465 | |
| Domain | Ran_BP1 | 9.69e-11 | 12 | 51 | 5 | PF00638 | |
| Domain | GRIP_dom | 9.69e-11 | 12 | 51 | 5 | IPR000237 | |
| Domain | GRIP | 9.69e-11 | 12 | 51 | 5 | PS50913 | |
| Domain | RANBD1 | 9.69e-11 | 12 | 51 | 5 | PS50196 | |
| Domain | RanBD | 1.57e-10 | 13 | 51 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 1.57e-10 | 13 | 51 | 5 | IPR000156 | |
| Domain | GCC2_Rab_bind | 1.72e-09 | 7 | 51 | 4 | IPR032023 | |
| Domain | Rab_bind | 1.72e-09 | 7 | 51 | 4 | PF16704 | |
| Domain | - | 1.02e-08 | 10 | 51 | 4 | 1.10.220.60 | |
| Domain | Wnt8 | 7.31e-06 | 2 | 51 | 2 | IPR013301 | |
| Domain | APC_dom | 7.31e-06 | 2 | 51 | 2 | IPR026831 | |
| Domain | APC_N | 7.31e-06 | 2 | 51 | 2 | IPR032038 | |
| Domain | APC_basic_dom | 7.31e-06 | 2 | 51 | 2 | IPR009234 | |
| Domain | Apc_fam | 7.31e-06 | 2 | 51 | 2 | IPR026818 | |
| Domain | APC_r | 7.31e-06 | 2 | 51 | 2 | PF05923 | |
| Domain | SAMP | 7.31e-06 | 2 | 51 | 2 | PF05924 | |
| Domain | APC_rpt | 7.31e-06 | 2 | 51 | 2 | IPR009223 | |
| Domain | SAMP | 7.31e-06 | 2 | 51 | 2 | IPR009224 | |
| Domain | APC_basic | 7.31e-06 | 2 | 51 | 2 | PF05956 | |
| Domain | APC_N_CC | 7.31e-06 | 2 | 51 | 2 | PF16689 | |
| Domain | TPR-contain_dom | 5.45e-05 | 150 | 51 | 5 | IPR013026 | |
| Domain | TPR_REGION | 8.57e-05 | 165 | 51 | 5 | PS50293 | |
| Domain | TPR | 8.57e-05 | 165 | 51 | 5 | PS50005 | |
| Domain | WxxW_domain | 1.09e-04 | 6 | 51 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.09e-04 | 6 | 51 | 2 | PF13330 | |
| Domain | PH_dom-like | 1.49e-04 | 426 | 51 | 7 | IPR011993 | |
| Domain | GPCR_3_mtglu_rcpt | 2.03e-04 | 8 | 51 | 2 | IPR000162 | |
| Domain | TPR | 4.22e-04 | 129 | 51 | 4 | SM00028 | |
| Domain | TPR-like_helical_dom | 4.26e-04 | 233 | 51 | 5 | IPR011990 | |
| Domain | TPR_repeat | 4.74e-04 | 133 | 51 | 4 | IPR019734 | |
| Domain | TIL | 4.74e-04 | 12 | 51 | 2 | PF01826 | |
| Domain | C8 | 4.74e-04 | 12 | 51 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 5.59e-04 | 13 | 51 | 2 | IPR014853 | |
| Domain | NCD3G | 5.59e-04 | 13 | 51 | 2 | PF07562 | |
| Domain | C8 | 5.59e-04 | 13 | 51 | 2 | SM00832 | |
| Domain | GPCR_3_9-Cys_dom | 5.59e-04 | 13 | 51 | 2 | IPR011500 | |
| Domain | TIL_dom | 6.51e-04 | 14 | 51 | 2 | IPR002919 | |
| Domain | GPCR_3_CS | 6.51e-04 | 14 | 51 | 2 | IPR017979 | |
| Domain | TSP_1 | 6.79e-04 | 63 | 51 | 3 | PF00090 | |
| Domain | TSP1 | 7.44e-04 | 65 | 51 | 3 | SM00209 | |
| Domain | TSP1_rpt | 7.44e-04 | 65 | 51 | 3 | IPR000884 | |
| Domain | TSP1 | 7.44e-04 | 65 | 51 | 3 | PS50092 | |
| Domain | Glyco_hormone_CN | 7.50e-04 | 15 | 51 | 2 | IPR006208 | |
| Domain | Cys_knot | 7.50e-04 | 15 | 51 | 2 | PF00007 | |
| Domain | VWD | 8.56e-04 | 16 | 51 | 2 | SM00216 | |
| Domain | VWF_type-D | 8.56e-04 | 16 | 51 | 2 | IPR001846 | |
| Domain | VWFD | 8.56e-04 | 16 | 51 | 2 | PS51233 | |
| Domain | VWD | 8.56e-04 | 16 | 51 | 2 | PF00094 | |
| Domain | LH2 | 1.09e-03 | 18 | 51 | 2 | SM00308 | |
| Domain | CTCK_1 | 1.09e-03 | 18 | 51 | 2 | PS01185 | |
| Domain | Wnt | 1.21e-03 | 19 | 51 | 2 | IPR005817 | |
| Domain | VWC_out | 1.21e-03 | 19 | 51 | 2 | SM00215 | |
| Domain | Wnt_CS | 1.21e-03 | 19 | 51 | 2 | IPR018161 | |
| Domain | wnt | 1.21e-03 | 19 | 51 | 2 | PF00110 | |
| Domain | WNT1 | 1.21e-03 | 19 | 51 | 2 | SM00097 | |
| Domain | WNT1 | 1.21e-03 | 19 | 51 | 2 | PS00246 | |
| Domain | GPCR_3 | 1.49e-03 | 21 | 51 | 2 | IPR000337 | |
| Domain | PLAT | 1.49e-03 | 21 | 51 | 2 | PS50095 | |
| Domain | - | 1.49e-03 | 21 | 51 | 2 | 2.60.60.20 | |
| Domain | PLAT | 1.49e-03 | 21 | 51 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.49e-03 | 21 | 51 | 2 | IPR001024 | |
| Domain | 7tm_3 | 1.63e-03 | 22 | 51 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.63e-03 | 22 | 51 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.63e-03 | 22 | 51 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.63e-03 | 22 | 51 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.63e-03 | 22 | 51 | 2 | PS50259 | |
| Domain | CT | 1.63e-03 | 22 | 51 | 2 | SM00041 | |
| Domain | GPCR_3_C | 1.63e-03 | 22 | 51 | 2 | IPR017978 | |
| Domain | Cys-rich_flank_reg_C | 1.91e-03 | 90 | 51 | 3 | IPR000483 | |
| Domain | TPR_1 | 1.91e-03 | 90 | 51 | 3 | PF00515 | |
| Domain | TPR_1 | 1.91e-03 | 90 | 51 | 3 | IPR001440 | |
| Domain | LRRCT | 1.91e-03 | 90 | 51 | 3 | SM00082 | |
| Domain | Cys_knot_C | 2.11e-03 | 25 | 51 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.11e-03 | 25 | 51 | 2 | PS01225 | |
| Domain | LRRNT | 2.43e-03 | 98 | 51 | 3 | IPR000372 | |
| Domain | LRRNT | 2.43e-03 | 98 | 51 | 3 | SM00013 | |
| Domain | - | 2.44e-03 | 207 | 51 | 4 | 1.25.40.10 | |
| Domain | VWC | 2.64e-03 | 28 | 51 | 2 | PF00093 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.65e-07 | 18 | 40 | 4 | MM1549 | |
| Pathway | BIOCARTA_WNT_LRP6_PATHWAY | 4.21e-07 | 6 | 40 | 3 | MM1588 | |
| Pathway | BIOCARTA_WNT_LRP6_PATHWAY | 4.21e-07 | 6 | 40 | 3 | M22083 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 4.45e-07 | 55 | 40 | 5 | M17807 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.65e-06 | 31 | 40 | 4 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.65e-06 | 31 | 40 | 4 | MM15154 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.72e-06 | 40 | 40 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.22e-06 | 41 | 40 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.75e-06 | 42 | 40 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.33e-06 | 43 | 40 | 4 | MM14609 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 7.61e-06 | 45 | 40 | 4 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 8.32e-06 | 46 | 40 | 4 | M47409 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.08e-06 | 47 | 40 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.07e-05 | 49 | 40 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.16e-05 | 50 | 40 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.26e-05 | 51 | 40 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.71e-05 | 55 | 40 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.11e-05 | 58 | 40 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.11e-05 | 58 | 40 | 4 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.32e-05 | 65 | 40 | 4 | MM15147 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.97e-05 | 68 | 40 | 4 | M27303 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 5.25e-05 | 73 | 40 | 4 | MM14948 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 6.42e-05 | 151 | 40 | 5 | M19428 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD4 RGPD4 USP18 FBXW10B FBXW10 RGPD8 FOLR1 RGPD3 RGPD1 APC MUC5B THSD7B MUC5AC | 7.37e-05 | 1389 | 40 | 13 | MM15307 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 7.90e-05 | 257 | 40 | 6 | MM14755 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 8.29e-05 | 82 | 40 | 4 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 9.10e-05 | 84 | 40 | 4 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 9.98e-05 | 86 | 40 | 4 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.30e-04 | 92 | 40 | 4 | MM14951 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.54e-04 | 37 | 40 | 3 | M47411 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.79e-04 | 100 | 40 | 4 | MM14561 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.49e-04 | 109 | 40 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.67e-04 | 111 | 40 | 4 | M27416 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.96e-04 | 114 | 40 | 4 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.27e-04 | 117 | 40 | 4 | MM15387 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 3.35e-04 | 48 | 40 | 3 | M39566 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.74e-04 | 129 | 40 | 4 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.63e-04 | 141 | 40 | 4 | MM15266 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.99e-04 | 143 | 40 | 4 | M27275 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 6.99e-04 | 14 | 40 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 6.99e-04 | 14 | 40 | 2 | M16173 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 8.05e-04 | 15 | 40 | 2 | M39442 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 8.05e-04 | 15 | 40 | 2 | MM1439 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 8.05e-04 | 15 | 40 | 2 | MM15845 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.19e-04 | 16 | 40 | 2 | M27410 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 9.19e-04 | 16 | 40 | 2 | M8516 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.01e-03 | 158 | 40 | 4 | MM14791 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.04e-03 | 17 | 40 | 2 | M27412 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 1.04e-03 | 17 | 40 | 2 | M39525 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.09e-03 | 161 | 40 | 4 | M39770 | |
| Pathway | REACTOME_SUMOYLATION | 1.30e-03 | 169 | 40 | 4 | MM14919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.30e-03 | 19 | 40 | 2 | M47836 | |
| Pathway | BIOCARTA_GSK3_PATHWAY | 1.44e-03 | 20 | 40 | 2 | M11106 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.59e-03 | 21 | 40 | 2 | MM15706 | |
| Pathway | BIOCARTA_GSK3_PATHWAY | 1.75e-03 | 22 | 40 | 2 | MM1421 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.78e-03 | 85 | 40 | 3 | M48315 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.91e-03 | 23 | 40 | 2 | M556 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.91e-03 | 23 | 40 | 2 | MM1527 | |
| Pathway | WNT_SIGNALING | 2.03e-03 | 89 | 40 | 3 | M5493 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 2.08e-03 | 24 | 40 | 2 | M16517 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.12e-03 | 193 | 40 | 4 | MM14890 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.14e-03 | 325 | 40 | 5 | M12868 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.26e-03 | 25 | 40 | 2 | MM14940 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 2.37e-03 | 94 | 40 | 3 | M797 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.44e-03 | 26 | 40 | 2 | M27483 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.44e-03 | 26 | 40 | 2 | M27239 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.50e-03 | 202 | 40 | 4 | MM15362 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 2.67e-03 | 98 | 40 | 3 | M39731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 2.83e-03 | 28 | 40 | 2 | M47835 | |
| Pathway | KEGG_MELANOGENESIS | 2.91e-03 | 101 | 40 | 3 | M7761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.04e-03 | 29 | 40 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.04e-03 | 29 | 40 | 2 | M47377 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.17e-03 | 233 | 40 | 4 | M27099 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 4.23e-03 | 234 | 40 | 4 | MM14898 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.51e-03 | 118 | 40 | 3 | M39852 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.56e-03 | 239 | 40 | 4 | MM14756 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 4.91e-03 | 37 | 40 | 2 | M17400 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.91e-03 | 37 | 40 | 2 | MM15067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY | 4.91e-03 | 37 | 40 | 2 | M47769 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.35e-03 | 250 | 40 | 4 | M27554 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 5.44e-03 | 39 | 40 | 2 | M793 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.44e-03 | 39 | 40 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.44e-03 | 39 | 40 | 2 | MM15165 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 6.89e-03 | 44 | 40 | 2 | MM15878 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 7.09e-03 | 271 | 40 | 4 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 7.09e-03 | 271 | 40 | 4 | MM15406 | |
| Pathway | PID_PS1_PATHWAY | 7.51e-03 | 46 | 40 | 2 | M70 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.65e-03 | 277 | 40 | 4 | MM15414 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 7.82e-03 | 144 | 40 | 3 | M39691 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.16e-13 | 7 | 51 | 5 | 15710750 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 21205196 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 18949001 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 25187515 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 9037092 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 8603673 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 26632511 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 24403063 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.43e-10 | 7 | 51 | 4 | 11353387 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 30944974 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 38838144 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.43e-10 | 7 | 51 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.43e-10 | 7 | 51 | 4 | 17372272 | |
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 38657106 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 12191015 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 22821000 | ||
| Pubmed | 1.43e-10 | 7 | 51 | 4 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.86e-10 | 8 | 51 | 4 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.86e-10 | 8 | 51 | 4 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.86e-10 | 8 | 51 | 4 | 28745977 | |
| Pubmed | 2.86e-10 | 8 | 51 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.86e-10 | 8 | 51 | 4 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.14e-10 | 9 | 51 | 4 | 18394993 | |
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 11553612 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 10601307 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 9733766 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 28100513 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 28877029 | ||
| Pubmed | 5.14e-10 | 9 | 51 | 4 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 8.55e-10 | 10 | 51 | 4 | 8857542 | |
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 8.55e-10 | 10 | 51 | 4 | 16332688 | |
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.34e-09 | 11 | 51 | 4 | 35771867 | |
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 17069463 | ||
| Pubmed | 1.34e-09 | 11 | 51 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.90e-09 | 13 | 51 | 4 | 31427429 | |
| Pubmed | 5.53e-09 | 15 | 51 | 4 | 14697343 | ||
| Pubmed | 2.94e-08 | 22 | 51 | 4 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.92e-07 | 38 | 51 | 4 | 12791264 | |
| Pubmed | 7.43e-07 | 215 | 51 | 6 | 35973513 | ||
| Pubmed | SAGE reveals expression of Wnt signalling pathway members during mouse prostate development. | 1.07e-06 | 14 | 51 | 3 | 16378759 | |
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 1.99e-06 | 17 | 51 | 3 | 28733458 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 7513696 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34058148 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27694902 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37146737 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32814052 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 2.11e-06 | 2 | 51 | 2 | 14988081 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15563276 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17621824 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24317696 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22391959 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 2.11e-06 | 2 | 51 | 2 | 35776514 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24327612 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 2.11e-06 | 2 | 51 | 2 | 21653907 | |
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 2.11e-06 | 2 | 51 | 2 | 31400758 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 2.11e-06 | 2 | 51 | 2 | 36427316 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 2.11e-06 | 2 | 51 | 2 | 28607090 | |
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 2.11e-06 | 2 | 51 | 2 | 23272068 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 2.11e-06 | 2 | 51 | 2 | 27729120 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 2.11e-06 | 2 | 51 | 2 | 23527003 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37450367 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16540890 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36111525 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11956596 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 2.11e-06 | 2 | 51 | 2 | 27845589 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27435107 | ||
| Pubmed | APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression. | 2.11e-06 | 2 | 51 | 2 | 31291912 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26871672 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 2.11e-06 | 2 | 51 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 2.11e-06 | 2 | 51 | 2 | 11587997 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 2.11e-06 | 2 | 51 | 2 | 24332705 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 2.11e-06 | 2 | 51 | 2 | 34656442 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27776277 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29286856 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 36675209 | ||
| Pubmed | Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. | 6.32e-06 | 3 | 51 | 2 | 26100173 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29802623 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 6.32e-06 | 3 | 51 | 2 | 34158522 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 6.32e-06 | 3 | 51 | 2 | 29604272 | |
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 6.32e-06 | 3 | 51 | 2 | 19596978 | |
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 6.32e-06 | 3 | 51 | 2 | 19556605 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 6.32e-06 | 3 | 51 | 2 | 21455588 | |
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 6.32e-06 | 3 | 51 | 2 | 20422702 | |
| Pubmed | Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. | 6.32e-06 | 3 | 51 | 2 | 18978302 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23840886 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19718741 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 6.68e-06 | 25 | 51 | 3 | 12812787 | |
| Pubmed | 7.97e-06 | 86 | 51 | 4 | 37253089 | ||
| Pubmed | 8.48e-06 | 27 | 51 | 3 | 17804636 | ||
| Pubmed | 9.48e-06 | 28 | 51 | 3 | 20940229 | ||
| Pubmed | 9.55e-06 | 90 | 51 | 4 | 19515997 | ||
| Pubmed | 1.06e-05 | 29 | 51 | 3 | 18364260 | ||
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 1.26e-05 | 4 | 51 | 2 | 31582416 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 25638393 | ||
| Interaction | RGPD4 interactions | 1.95e-09 | 22 | 50 | 5 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 5.93e-09 | 27 | 50 | 5 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 1.09e-07 | 47 | 50 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 1.34e-07 | 49 | 50 | 5 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 1.08e-06 | 74 | 50 | 5 | int:RGPD8 | |
| Interaction | RAN interactions | 2.21e-06 | 475 | 50 | 9 | int:RAN | |
| Interaction | RGPD5 interactions | 3.95e-06 | 96 | 50 | 5 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 1.14e-05 | 18 | 50 | 3 | int:NPIPB6 | |
| Interaction | FBXW10B interactions | 1.81e-05 | 3 | 50 | 2 | int:FBXW10B | |
| Interaction | RANBP2 interactions | 2.88e-05 | 361 | 50 | 7 | int:RANBP2 | |
| Interaction | RPS29 interactions | 8.67e-05 | 182 | 50 | 5 | int:RPS29 | |
| Interaction | IRAK3 interactions | 9.68e-05 | 36 | 50 | 3 | int:IRAK3 | |
| Interaction | RCC1 interactions | 1.38e-04 | 201 | 50 | 5 | int:RCC1 | |
| Cytoband | 2q13 | 6.15e-05 | 68 | 51 | 3 | 2q13 | |
| Cytoband | 17p12 | 1.38e-03 | 49 | 51 | 2 | 17p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q22 | 1.99e-03 | 59 | 51 | 2 | chr5q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 3.80e-03 | 82 | 51 | 2 | chr2q12 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.62e-06 | 115 | 39 | 5 | 769 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.08e-04 | 43 | 39 | 3 | 409 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.26e-04 | 8 | 39 | 2 | 281 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 2.46e-04 | 11 | 39 | 2 | 559 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.58e-04 | 19 | 39 | 2 | 360 | |
| GeneFamily | CD molecules|Mucins | 9.28e-04 | 21 | 39 | 2 | 648 | |
| GeneFamily | WD repeat domain containing | 2.38e-03 | 262 | 39 | 4 | 362 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 4.99e-07 | 33 | 51 | 4 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.48e-06 | 43 | 51 | 4 | MM3857 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-08 | 196 | 51 | 6 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-08 | 196 | 51 | 6 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-06 | 196 | 51 | 5 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-06 | 196 | 51 | 5 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-06 | 197 | 51 | 5 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-06 | 197 | 51 | 5 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.05e-06 | 197 | 51 | 5 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.05e-06 | 197 | 51 | 5 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.05e-06 | 197 | 51 | 5 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.05e-06 | 197 | 51 | 5 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.06e-05 | 141 | 51 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 2.30e-05 | 145 | 51 | 4 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.38e-05 | 171 | 51 | 4 | 459e1ac0b89571c39db98c0f578eca8f46caa8e3 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.48e-05 | 172 | 51 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 173 | 51 | 4 | e4d9a9a781acc531bc81c3fcee24d637e805c8e1 | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 4.58e-05 | 173 | 51 | 4 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 175 | 51 | 4 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.79e-05 | 175 | 51 | 4 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 5.01e-05 | 177 | 51 | 4 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.23e-05 | 179 | 51 | 4 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.23e-05 | 179 | 51 | 4 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 179 | 51 | 4 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 5.35e-05 | 180 | 51 | 4 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.35e-05 | 180 | 51 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 180 | 51 | 4 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-05 | 180 | 51 | 4 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 181 | 51 | 4 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 181 | 51 | 4 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 181 | 51 | 4 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 5.70e-05 | 183 | 51 | 4 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 184 | 51 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.82e-05 | 184 | 51 | 4 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Control-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 5.95e-05 | 185 | 51 | 4 | 9a793e6016295a63820e9d7563f195494ac692e7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 188 | 51 | 4 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.33e-05 | 188 | 51 | 4 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 190 | 51 | 4 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.87e-05 | 192 | 51 | 4 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 6.87e-05 | 192 | 51 | 4 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-05 | 192 | 51 | 4 | 6c269d2426f76559d2ed3bf2169eb4be5fc7ad6d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 193 | 51 | 4 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-05 | 195 | 51 | 4 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 196 | 51 | 4 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.44e-05 | 196 | 51 | 4 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 196 | 51 | 4 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.44e-05 | 196 | 51 | 4 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.58e-05 | 197 | 51 | 4 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.58e-05 | 197 | 51 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.58e-05 | 197 | 51 | 4 | e2c820c4e4a6cd01ceb020473286e3f5d4e3718e | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 7.58e-05 | 197 | 51 | 4 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.58e-05 | 197 | 51 | 4 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.58e-05 | 197 | 51 | 4 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.73e-05 | 198 | 51 | 4 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.73e-05 | 198 | 51 | 4 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.73e-05 | 198 | 51 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.73e-05 | 198 | 51 | 4 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | medial-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 4737250b7ffa7cc19eb6b057d35d78f13b1afe66 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-05 | 199 | 51 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | f37114cf849837fdb8ed9a767de773e8681b7df3 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.89e-05 | 199 | 51 | 4 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.89e-05 | 199 | 51 | 4 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | medial-Epithelial-Mucous|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 4385963ab25b5378e7964b984028c25b27e5794e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.89e-05 | 199 | 51 | 4 | 2b17694cffbec28a2c8f165dfcff6bab94aa0f4c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5B+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.89e-05 | 199 | 51 | 4 | 4ab45996e6bca406c77895a5998982b8ab1cf210 | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Club|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.89e-05 | 199 | 51 | 4 | 111cfd589ec6795075d8d88d7664bfb23eba5bf6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-05 | 199 | 51 | 4 | d583290a1d288b749ad17bc501c1487268c6551c | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | distal-2-Epithelial-Mucous|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | c0275b5011c2bb08e873955afe2e213ec8070d0e | |
| ToppCell | distal-Epithelial-Mucous-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 0af89ef40807fc4ad79ab82a2186ab6e866c6931 | |
| ToppCell | medial-Epithelial-Mucous-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | 53198bcf5f2f012a3ed1600d95c0923d6976a099 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.89e-05 | 199 | 51 | 4 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.89e-05 | 199 | 51 | 4 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | distal-Epithelial-Mucous|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.89e-05 | 199 | 51 | 4 | a7fe7b792d696f369ad0310a772160a1729ef223 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.04e-05 | 200 | 51 | 4 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.04e-05 | 200 | 51 | 4 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 8.68e-05 | 204 | 51 | 4 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 99 | 51 | 3 | 98c40a27432929434879c9e7283a14102f405f39 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 99 | 51 | 3 | d6bd8075dc7aba2034ea78b1389868282bc80a2d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.65e-04 | 109 | 51 | 3 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 121 | 51 | 3 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.44e-04 | 130 | 51 | 3 | eb16a8f8f62add5fdd29c78d4608b6d1a06767f1 | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 133 | 51 | 3 | 2caaacb4fb4358c5589c81eaf8dffb85f318fb13 | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 133 | 51 | 3 | 2d0cade52d79c3d0b6f77418103244150e2ea7fb | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 133 | 51 | 3 | 25ea1d82a0fc9fed191b9dd33f2a35404a665e7d | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 133 | 51 | 3 | 51c60b6d5648968783bffbb22c28d9abaf6243d5 | |
| ToppCell | Globus_pallidus-Macroglia-CSF_related-EPENDYMAL-Ependymal_(Ccdc153)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.74e-04 | 133 | 51 | 3 | a653282bf871dc9eb47fbf1d55b1eb32ae749c04 | |
| ToppCell | severe-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.06e-04 | 136 | 51 | 3 | 56a7b5c2e098b4a49124d1b905257a52eb38b519 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 137 | 51 | 3 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 137 | 51 | 3 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.50e-04 | 140 | 51 | 3 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.86e-04 | 143 | 51 | 3 | abe6ec0f6956b87f394d537926eb2427fcfad93f | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-2|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 6.10e-04 | 145 | 51 | 3 | f9aa7f2401e26f1e8cec1112a71c16e1c2784893 | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.02e-06 | 168 | 51 | 6 | 4671_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.21e-06 | 182 | 51 | 6 | 2321_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.64e-06 | 194 | 51 | 6 | 1632_UP | |
| Drug | erythromycin stearate | 4.94e-06 | 111 | 51 | 5 | CID000012559 | |
| Drug | 2-aminosuberic acid | 4.90e-05 | 5 | 51 | 2 | CID000077937 | |
| Drug | LY393675 | 4.90e-05 | 5 | 51 | 2 | CID005311262 | |
| Drug | DMeOB | 4.90e-05 | 5 | 51 | 2 | CID002061047 | |
| Drug | tyrphostin B52 | 4.90e-05 | 5 | 51 | 2 | CID005328773 | |
| Drug | AC1MBZ3L | 7.34e-05 | 6 | 51 | 2 | CID002733524 | |
| Drug | MTEP | 7.34e-05 | 6 | 51 | 2 | CID009794218 | |
| Drug | SIB-1757 | 7.34e-05 | 6 | 51 | 2 | CID006304902 | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 4747_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 4593_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 4813_UP | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 6669_UP | |
| Drug | CGS 19755 | 8.45e-05 | 38 | 51 | 3 | CID000068736 | |
| Drug | CDPPB | 1.03e-04 | 7 | 51 | 2 | CID011245456 | |
| Drug | azetidine-2,4-dicarboxylic acid | 1.03e-04 | 7 | 51 | 2 | CID000005370 | |
| Drug | MCCG-I | 1.03e-04 | 7 | 51 | 2 | CID005311457 | |
| Drug | 1-aminocyclopentane-1,3-dicarboxylate | 1.12e-04 | 111 | 51 | 4 | CID000001310 | |
| Disease | familial adenomatous polyposis 1 (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:0080409 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 1.04e-04 | 57 | 47 | 3 | EFO_0000768 | |
| Disease | Colorectal Carcinoma | 1.15e-04 | 702 | 47 | 7 | C0009402 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.28e-04 | 61 | 47 | 3 | DOID:3587 (is_marker_for) | |
| Disease | pulmonary fibrosis | 1.35e-04 | 11 | 47 | 2 | EFO_0009448 | |
| Disease | interstitial lung disease | 1.69e-04 | 67 | 47 | 3 | EFO_0004244 | |
| Disease | Alcoholic Intoxication, Chronic | 8.73e-04 | 268 | 47 | 4 | C0001973 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.05e-03 | 30 | 47 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | asthma (is_marker_for) | 1.07e-03 | 126 | 47 | 3 | DOID:2841 (is_marker_for) | |
| Disease | chronic rhinosinusitis | 1.35e-03 | 34 | 47 | 2 | EFO_1000024 | |
| Disease | Inflammatory Bowel Diseases | 1.43e-03 | 35 | 47 | 2 | C0021390 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.43e-03 | 35 | 47 | 2 | C0752122 | |
| Disease | COVID-19 symptoms measurement | 1.43e-03 | 35 | 47 | 2 | EFO_0600019 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASWRLWAIKDFQECT | 31 | Q6ZRH7 | |
| LSNWSEWTDCFPCQD | 41 | P07357 | |
| SICYFEQENDWWVCK | 121 | O15143 | |
| WKIFSTKEWFCRIND | 36 | Q5XX13 | |
| TKCRGLWWECVTNAF | 41 | Q9Y5I7 | |
| TTRCQPKCEWTEWFD | 1781 | Q9HC84 | |
| CKQLCTERQKSWWDA | 521 | Q99666 | |
| CKQLCTERQKSWWDA | 521 | O14715 | |
| WKIFSTKEWFCRIND | 36 | O95170 | |
| RSCQDWCDRKQHWLE | 6 | Q5VTT2 | |
| FFNCSCDIRWMQLWQ | 161 | Q16288 | |
| DQWREWADSKSCCDY | 121 | Q16555 | |
| CTWDGCSWKFARSDE | 306 | O95600 | |
| CWKDLDDFNRIFWCG | 196 | P16050 | |
| EICWTNSESFAAWCR | 206 | Q96KN4 | |
| DCHLRCTWTKWFDID | 3221 | P98088 | |
| NDKELRFQWSCGSCW | 586 | Q7Z442 | |
| CKQLCTERQKSWWDA | 521 | A6NKT7 | |
| FRDQWERSWVAQSCK | 561 | Q9UP38 | |
| QIRAYCETCWDWLQA | 376 | O95996 | |
| WFAEFWEENFNCKLT | 356 | O15303 | |
| TCTWKAWEDTLDKYC | 356 | Q16610 | |
| VQDEFTCKACDLGWW | 556 | Q13255 | |
| KEDCEQWWEDCRTSY | 136 | P15328 | |
| QWWEDCRTSYTCKSN | 141 | P15328 | |
| CTERQKSWWDAVCTL | 516 | P0DJD0 | |
| VWKIASDCFRFQDWS | 126 | Q9NPJ8 | |
| FSWALDFCKACWKLQ | 331 | P21217 | |
| CKQLCTERQKSWWDA | 521 | Q7Z3J3 | |
| HNFCKACITRWWEDL | 46 | Q9HCM9 | |
| ECDCNLREFKHWMEW | 201 | Q8N967 | |
| WRFAVCSFRDAWEEE | 21 | Q58EX7 | |
| SWFWDRDEACFDLNP | 451 | Q96D09 | |
| WQFDCTDLWETCVRC | 656 | P08F94 | |
| WICRDARAFEWFADL | 441 | Q9HBY0 | |
| EQIRAYCETCWEWQE | 411 | P25054 | |
| WNDNRCDVDNYWICK | 376 | Q9H2X3 | |
| CDFREDWQTWDCPKT | 321 | Q12884 | |
| IEECKYQFAWDRWNC | 51 | Q93098 | |
| PFDCTCESIAWFVNW | 646 | O15455 | |
| NQEESCKVDDFSWAW | 341 | C9JQI7 | |
| WNRTFSWGFDDFSCC | 2901 | Q6ZS81 | |
| FICNECGKSFSWWSA | 446 | Q96BV0 | |
| CWFCGRVFDNQDTWA | 1451 | Q6AHZ1 | |
| TVYKCNWDDDSFCWI | 211 | Q9UJW7 | |
| WFCFNDSNICLVSWE | 331 | Q3LFD5 | |
| WFCFNDSNICLVSWE | 331 | Q9UMW8 | |
| FYTWEACDDACWRIE | 76 | P48307 | |
| IEECKFQFAWERWNC | 51 | Q9H1J5 | |
| CYSWVLGNWSACKLE | 1301 | Q9C0I4 | |
| SWFLTEWSERCSAEC | 796 | Q6ZMP0 | |
| RVSTAEWCFCFWREK | 296 | Q92563 | |
| WDSRFCSLKCQEEFW | 931 | Q5FWF4 |